Comparative effects of mulligan’s mobilization and proprioceptive neuromuscular facilitation technique on pain and disability in patients with sacroiliac joint dysfunction

Purpose: To evaluate the efficacy of Mulligan’s Movement of Mobilization and contract- relax technique on pain and disability in patients suffering from sacroiliac joint Dysfunction. Method: A randomized clinical trial was done at DHQ hospital Jhang. 38 persons including both genders old enough 20-35 years were associated with this review who meet the inclusion criteria were recruited by consecutive sampling technique and allocated to the groups by simple random sampling process and by sealed opaque enveloped labeled as 0 for group A and 1 for group B and indiscriminately allocated into two sets. One set A was specified to mulligan mobilization technique and the second set B was specified to contract-relax technique for 6 weeks as three sessions per week. Baseline treatment of hot pack and ultrasound was given to both groups. All the patients were assessed for pain with NPRS and for disability with MOPDQ before and after treatment. Data was analyzed using SPSS 22. Results: After treatment, both groups significantly improved in terms of pain and disability. Mean value of NPRS was reduced from 6.89±1.15 to 1.68±.58 in MWM Group while in Contract-Relax from 6.78±1.18 to 2.57±.90. Mean Value of MOPDQ improved from 31.00±6.24 to 2.95±.911 and 32.26±7.14 to 4.31±1.20 in MWM and Contract-Relax group. However, group that received mulligan technique had significantly better improved NPRS and MOPDQ values than contract-relax group in patients with Sacro-iliac dysfunction (p<0.05). Conclusion: In the management of sacroiliac joint dysfunction, Mulligan mobilization is more efficient than contract-relax approach

A RELIABILITY AND VALIDITY STUDY OF THE URDU VERSION OF THE UNIFIED PARKINSON DISEASE RATING SCALE

Introduction: In order to evaluate the severity and progression of Parkinson's disease, the Unified Parkinson Disease Rating Scale (UPDRS) is commonly used. An important aspect of any rating scale, including the UPDRS, is its reliability and validity. Material & Methods: In this cross-sectional study, data were collected between October 2020 and January 2021. In accordance with standard guidelines for translating UPDRS into Urdu, 215 Parkinson's disease patients who met predefined inclusion criteria were administered the final Urdu version.Cronbach alpha was used to determine an inter-item correlation. A test-retest reliability analysis was conducted by comparing UPDRS-U scores at baseline and after two weeks. We also compared the scores of two observers in order to determine inter-rater reliability. Concurrent validity was established using the Spearman correlation coefficient. Results: UPDRS-U had a Cronbach alpha score of 0.940, indicating internal consistency. The Spearman correlation coefficient for UPDRS-U composite scores at baseline and two weeks later was 0.82, suggesting excellent test-retest reliability.According to this study, UPDRS-U and BBS have good concurrent validity (rs =-.808, p=0.001) and UPDRS and ABC have good concurrent validity (rs =-.791, p=0.001). Furthermore, the two observers' UPDRS-U scores were positively correlated, with a spearman correlation coefficient of 0.97 and P< 0.001 indicating good inter-rater reliability. Correlations between individual item scores and the UPDRS total item score were found to range between 0.194 and 0.866. Conclusion: UPDRS-U was found to be a reliable and valid tool for assessing Parkinson disease symptoms and progression among Pakistani adults